C-sections accountfor more than 30 percent of all deliveries in the US, at roughly 1.5 times the average costs of a normal delivery, when the medically indicated rate is easily less than half that.
Until researchers can come out with a potent enough antiviral combo to accountfor the massive numbers of mutations that hepatitis c virus can produce, interferon will remain part of hepatitis C treatments.